July 9, 2019,Under the recommendation of Dean Hu Wenzhong from the School of Life Sciences at Dalian Minzu University, Chairman Wu from Zhuhai Miditech Biopharmaceutical Co., Ltd. visited Dalian Xinyi.

Dalian Xinyi Chairman Li Yan (first from the left) and Chairman Wu from Miditech.

On July 22, 2019, Ms. Li Yan, Chairman of Dalian Xinyi, along with senior management, visited Zhuhai Miditech Biopharmaceutical Co., Ltd. (hereinafter referred to as "Miditech"). The two parties had friendly exchanges and discussions on cooperation in areas such as the cultivation and planting of American Taxus media and the extraction technology of paclitaxel.

Chairman of Miditech and company representatives warmly received the visit.

Chairman Li Yan of Dalian Xinyi and her team visited the Miditech factory and biopharmaceutical base under the explanation of Miditech's researchers.

Miditech's intelligent pharmaceutical process

Miditech's first-class production line

Miditech's large-scale automated equipment

Researchers provided a detailed introduction to the exclusive patent "New Anti-Liver Cancer Drug - Sanjie Pian" bioproduct research technology. Chairman Li Yan expressed her appreciation for Miditech's corporate culture, scale strength, product quality, and R&D technology.

The two parties held discussions on the implementation of corporate cooperation matters.

Chairman Wu Xiukun of Miditech Group

Chairman Li Yan of Xinyi Agriculture

At the meeting, Chairman Wu of Miditech welcomed the visit of Chairman Li Yan and her team from Xinyi Agriculture, and provided a detailed introduction to the pharmaceutical process, drug efficacy, and anti-cancer efficacy of the "New Anti-Liver Cancer Drug - Sanjie Pian" product, which has obtained a national invention patent. Chairman Li Yan praised the advanced biopharmaceutical process of the "New Anti-Liver Cancer Drug - Sanjie Pian."
At the meeting, General Manager Li Fengmei of Xinyi Agriculture analyzed the extraction of paclitaxel from Taxus media, its anti-cancer efficacy, and development prospects. Chairman Wu recognized the analysis of paclitaxel development by General Manager Li Fengmei. The two parties conducted in-depth discussions on future cooperation directions, cooperation models, and reached multiple consensuses on corporate information technology cooperation.

Miditech, a leader in biopharmaceuticals

Miditech is a key investment attraction project in Zhuhai City, located in the Zhuhai Bio-Industry Park, covering an area of 50 acres, with a construction area of 13,000 square meters in the first phase. It has obtained a national invention patent (ZL200410050749.3) for the new anti-liver cancer drug - Sanjie Pian, with a national drug approval number Z20040106, and is an exclusive patent that can effectively treat liver cancer while also preventing the transformation of liver cirrhosis and ascites into liver cancer.
There are also new drugs such as Baishan Pian for treating lung cancer, nasopharyngeal cancer, and laryngeal cancer; Xiaojieling for treating gastric cancer, intestinal cancer, and pancreatic cancer; and Rukangning for treating breast cancer and uterine cancer, all of which have obtained national invention patents.

Dalian Xinyi Agriculture Base is also the largest breeding base for American Taxus media in the country, providing raw materials for the anti-cancer drug paclitaxel to major pharmaceutical manufacturers with the advantage of a thousand-acre Taxus planting forest.

American Taxus media, the anti-cancer miracle tree

Taxus media is a rare and endangered species that has survived since the Quaternary glacial period 2.5 million years ago, known as a living fossil among plants, with medicinal value and air purification effects, truly deserving the title of "plant panda."

Taxus media (Taxus madia),one of the highest oxygen-releasing green plants in the world,its paclitaxel content is several times that of southern or northern Taxus,and paclitaxelis currently the best natural anti-cancer drug discovered,it can also be said to be the "anti-cancer miracle tree."

Taxus can absorb 90% of indoor benzene, 86% of formaldehyde, and harmful gases such as nitrogen peroxide and nicotine. Placing several Taxus bonsai indoors can effectively eliminate symptoms such as headaches, nausea, and poor mood that office workers may experience, making you feel refreshed and energetic.